| ESCC | esophageal squamous cell carcinoma |
| G/GEJ | gastric/gastroesophageal junction |
| HCC | hepatocellular carcinoma |
| PDAC | pancreatic ductal adenocarcinoma |
| DCR | disease control rate |
| PD | progressive disease |
| TRAEs | treatment-related adverse events |
| irAEs | immune-related adverse events |
| OS | overall survival |
| PFS | progression-free survival |
| CI | confidence interval |